Boston University et al report that “timely receipt of buprenorphine, naltrexone, or methadone was associated with greater retention in care among youths with OUD compared with behavioral treatment only” – but it’s keeping young people on substitute drugs for up to a year (so far) rather than rehabs weaning them off drugs in a fraction of that time.


